Medicare Enrolled
Dr. Shariar Cohen-Gadol, M.D.
Magnetic Resonance Imaging (MRI) Clinic/Center · Thousand Oaks, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Cohen-Gadol from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cohen-Gadol?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Cohen-Gadol
Dr. Shariar Cohen-Gadol is a magnetic resonance imaging clinic/center specialist in Thousand Oaks, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Cohen-Gadol performed 529,156 Medicare services across 8,083 unique beneficiaries.
Between the years covered by Open Payments, Dr. Cohen-Gadol received a total of $280,734 from 74 pharmaceutical and/or device companies across 2781 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in magnetic resonance imaging (mri) clinic/center. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Cohen-Gadol is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ 529,156 Medicare services
$280,734 industry payments
Medicare Practice Summary
Medicare Utilization ↗529,156
Medicare services
1.0× state median for magnetic resonance imaging (mri) clinic/center
8,083
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~27,850 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Certolizumab injection (Cimzia) An injection of certolizumab pegol administered under the direct supervision of a physician. |
169,200 | $4 | $12 |
| Romosozumab injection (Evenity) for osteoporosis | 132,510 | $8 | $20 |
| Tocilizumab injection (Actemra) | 64,960 | $5 | $14 |
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
60,500 | $10 | $51 |
| Denosumab injection (Prolia/Xgeva) | 46,440 | $18 | $40 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
15,500 | $34 | $137 |
| Rituximab injection, 10 mg Administration of a 10 mg dose of rituximab medication via injection. |
14,050 | $63 | $250 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
4,036 | $26 | $159 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,953 | $102 | $236 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
2,689 | $12 | $58 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
2,357 | $0 | $5 |
| Anti-nausea injection (ondansetron/Zofran) | 1,357 | $0 | $20 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
1,196 | $133 | $318 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
1,110 | $120 | $316 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
1,012 | $67 | $174 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
961 | $14 | $65 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
935 | $84 | $216 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
814 | $25 | $164 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
776 | $9 | $60 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
648 | $4 | $25 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
541 | $74 | $162 |
| X-ray of hand, minimum of 3 views An X-ray imaging test of the hand that captures at least three different angles to visualize the bones and joints. |
389 | $33 | $70 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
339 | $1 | $16 |
| Knee X-ray, 3 views An X-ray imaging test of the knee joint that captures three different angles to evaluate the bones and surrounding structures. |
321 | $37 | $82 |
| New patient office visit, complex (60-74 min) | 318 | $171 | $450 |
| Wrist X-ray, minimum 3 views An imaging test using X-rays to capture at least three different angles of the wrist bones and joints. |
292 | $37 | $82 |
| Hyaluronan gel injection for joint An injection of hyaluronan gel into a joint to supplement joint fluid. This procedure is administered as a single dose. |
285 | $404 | $1,500 |
| Injection, methylprednisolone acetate, 40 mg | 273 | $6 | $40 |
| Foot X-ray, 3+ views An X-ray imaging test of the foot that captures at least three different views to evaluate the bones and joints. |
190 | $31 | $68 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
160 | $1 | $10 |
| Hyaluronan injection (Euflexxa) for joint An injection of hyaluronan or its derivative, specifically Euflexxa, administered directly into a joint space. |
159 | $100 | $300 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
158 | $57 | $172 |
| Ankle X-ray, minimum 3 views An X-ray imaging test of the ankle that captures at least three different angles to evaluate the bones and joints. |
153 | $33 | $72 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
150 | $6 | $60 |
| Shoulder X-ray, 2+ views An X-ray imaging test of the shoulder joint using at least two different angles to visualize the bones and surrounding structures. |
144 | $31 | $66 |
| Methotrexate sodium, 5 mg | 137 | $0 | $1 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
105 | $0 | $35 |
| Methylprednisolone acetate injection, 20 mg A 20 mg injection of methylprednisolone acetate, a corticosteroid medication. This code specifies the drug and dosage administered. |
101 | $5 | $20 |
| Ultrasound-guided small joint aspiration or injection This procedure involves removing fluid from or injecting medication into a small joint while using ultrasound imaging to guide the needle placement. |
97 | $69 | $177 |
| Pelvis X-ray, minimum 3 views An X-ray imaging test of the pelvic area that captures at least three different views to evaluate the bones and joints. |
96 | $38 | $88 |
| X-ray of lower and sacral spine, 2-3 views An X-ray imaging test that captures 2 to 3 views of the lower back and sacral spine to visualize the bones and joints in this area. |
92 | $35 | $80 |
| X-ray of upper spine, 2-3 views An X-ray imaging test of the upper spine using two to three different angles to visualize the bones and structures. |
88 | $33 | $76 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
82 | $1 | $40 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
80 | $53 | $90 |
| Joint fluid aspiration or injection, small joint Removal of fluid from a small joint or injection of medication into a small joint. |
71 | $38 | $106 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
61 | $29 | $65 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
53 | $48 | $98 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
38 | $52 | $144 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
33 | $44 | $138 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
30 | $41 | $120 |
| Ultrasound-guided joint aspiration or injection Removal of fluid from or injection into a medium-sized joint using ultrasound guidance to ensure accurate placement. |
28 | $80 | $186 |
| X-ray of middle spine, 2 views An X-ray imaging test that produces two views of the middle section of the spine to visualize the bones and joints. |
21 | $29 | $78 |
| Lower back and sciatic nerve injection An injection of an anesthetic and/or steroid medication into the lower back and sciatic nerve. This procedure delivers medication directly to the nerve site. |
19 | $110 | $312 |
| Elbow X-ray, minimum 3 views An X-ray imaging test of the elbow joint that captures at least three different angles to visualize the bones and surrounding structures. |
19 | $29 | $72 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
15 | $125 | $360 |
| Tendon or ligament injection A procedure involving the injection of medication into a tendon or ligament. |
14 | $48 | $132 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
15.4% high complexity
83.3% medium
1.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$280,734
Total received (2018-2024)
Avg $40,105/year across 7 years
1.0× state median for specialty
74
Companies
2,781
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$241,627 (86.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$30,971 (11.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$8,136 (2.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$14,874
2023
$21,860
2022
$53,052
2021
$32,746
2020
$41,343
2019
$71,920
2018
$44,938
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$9,451
ABBVIE INC.
$2,396
Janssen Biotech, Inc.
$669
UCB, Inc.
$458
Novartis Pharmaceuticals Corporation
$379
Kiniksa Pharmaceuticals International, plc
$209
Radius Health, Inc.
$203
PFIZER INC.
$196
Genentech USA, Inc.
$141
AstraZeneca Pharmaceuticals LP
$113
Azurity Pharmaceuticals, Inc.
$79
Mallinckrodt Hospital Products Inc.
$79
GlaxoSmithKline, LLC.
$78
ANI Pharmaceuticals, Inc.
$69
Lilly USA, LLC
$67
ARGENX US, INC.
$59
Fidia Pharma USA Inc.
$54
DePuy Synthes Sales Inc.
$50
Bioventus LLC
$29
Zimmer Biomet Holdings, Inc.
$28
E.R. Squibb & Sons, L.L.C.
$21
Abbott Laboratories
$19
Teva Pharmaceuticals USA, Inc.
$14
Almatica Pharma LLC
$13
Top 3 companies account for 84.1% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$91,027
Horizon Therapeutics plc
$64,742
Amgen Inc.
$28,594
Horizon Pharma plc
$26,719
Celgene Corporation
$14,153
Janssen Scientific Affairs, LLC
$8,225
Novartis Pharmaceuticals Corporation
$7,418
AbbVie, Inc.
$6,958
AbbVie Inc.
$6,573
Janssen Biotech, Inc.
$5,288
ABBVIE INC.
$4,104
GlaxoSmithKline, LLC.
$3,145
UCB, Inc.
$2,504
PFIZER INC.
$1,590
AstraZeneca Pharmaceuticals LP
$879
Genentech USA, Inc.
$847
Radius Health, Inc.
$796
Mallinckrodt Hospital Products Inc.
$627
Alexion Pharmaceuticals, Inc.
$459
E.R. Squibb & Sons, L.L.C.
$432
GENZYME CORPORATION
$416
Ferring Pharmaceuticals Inc.
$408
Takeda Pharmaceuticals U.S.A., Inc.
$330
Teva Pharmaceuticals USA, Inc.
$285
Merck Sharp & Dohme Corporation
$248
ARBOR PHARMACEUTICALS, INC.
$244
Mallinckrodt Enterprises LLC
$231
Hikma Pharmaceuticals USA
$220
Azurity Pharmaceuticals, Inc.
$214
Kiniksa Pharmaceuticals International, plc
$209
Flexion Therapeutics, Inc.
$204
Fidia Pharma USA Inc.
$165
FIDIA PHARMA USA INC.
$164
Kowa Pharmaceuticals America, Inc.
$160
Boehringer Ingelheim Pharmaceuticals, Inc.
$156
Mallinckrodt LLC
$144
Organon LLC
$124
Boston Scientific Corporation
$118
ANI Pharmaceuticals, Inc.
$102
West-Ward Pharmaceuticals
$96
SOBI, INC
$91
Biohaven Pharmaceuticals, Inc.
$87
DePuy Synthes Sales Inc.
$83
Kiniksa Pharmaceuticals, Ltd.
$79
Sobi, Inc
$77
ASSERTIO THERAPEUTICS, Inc.
$71
MEDAC PHARMA, INC.
$65
Allergan, Inc.
$63
ARGENX US, INC.
$59
Zimmer Biomet Holdings, Inc.
$59
Eisai Inc.
$52
Antares Pharma, Inc.
$50
Aurinia Pharma U.S., Inc.
$50
Exeltis, USA Inc.
$48
SANOFI-AVENTIS U.S. LLC
$44
Sandoz Inc.
$43
Daiichi Sankyo Inc.
$39
Zyla Life Sciences, Inc.
$37
Octapharma USA, Inc.
$34
Bioventus LLC
$29
GRT US Holding, Inc.
$27
Kyowa Kirin, Inc.
$27
Allergan Inc.
$24
Arbor Pharmaceuticals, Inc.
$24
Shionogi Inc
$22
Lundbeck LLC
$21
Abbott Laboratories
$19
Bio Products Laboratory USA, Inc.
$18
Sun Pharmaceutical Industries Inc.
$18
Endo Pharmaceuticals Inc.
$15
Vertical Pharmaceuticals, LLC
$13
Almatica Pharma LLC
$13
Gilead Sciences, Inc.
$12
Team_Makena_LLC
$4
Top 3 companies account for 65.7% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AIMOVIG · AJOVY · AMJEVITA · AVSOLA · Actemra · Adthyza · Aimovig · Amitiza · Arcalyst · BELSOMRA · BENLYSTA · Bimzelx · COSENTYX · Cimzia · Crysvita · DUEXIS · DUROLANE · Dayvigo · EUFLEXXA · EVENITY · EVUSHELD · Edarbi · Enbrel · FORTEO · GENERAL PAIN MANAGEMENT · Gammaplex · Gel-One Cross-linked Hyaluronate · Gralise · HADLIMA · HORIZANT · HUMIRA · HYALGAN · HYMOVIS · HYRIMOZ · Horizant · Humira · Hymovis · ILARIS · ILUMYA · INFLECTRA · INJECTAFER · KEVZARA · KINERET · KRYSTEXXA · Kineret · LORZONE · LUPKYNIS · LYRICA · MONOVISC · MOTEGRITY · Mitigare · NEXPLANON · NURTEC ODT · OFEV · OLUMIANT · ORENCIA · ORTHOVISC · OTREXUP · Otezla · Otrexup · PANZYGA · PENNSAID · PROCLAIM · PURIFIED CORTROPHIN GEL · Prolia · QULIPTA · Qutenza · RAYOS · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SEGLENTIS · SIMPONI · SIMPONI ARIA · SKYRIZI · SPRIX · STELARA · STRENSIQ · SYMBICORT · SYNVISC-ONE · Seglentis · Sports Medicine-None · Strensiq · Symproic · TALTZ · TAVNEOS · TERIPARATIDE · TREMFYA · TRINTELLIX · Trintellix · Truxima · Tymlos · UBRELVY · UPLIZNA · Uloric · VIBERZI · VIIBRYD · VYEPTI · VYVGART HYTRULO · XELJANZ · XIAFLEX · Zilretta · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (86%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in magnetic resonance imaging (mri) clinic/center and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
Magnetic resonance imaging clinic/centers within 10 mi
1
Per 100K population
0.1
County median income
$107,327
Nearest hospital
LOS ROBLES HOSPITAL & MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Cohen-Gadol is a mixed practice specialist, with speaking/promotional industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Cohen-Gadol experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Cohen-Gadol performed 169,200 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Cohen-Gadol receive payments from pharmaceutical companies?
Yes. Dr. Cohen-Gadol received a total of $280,734 from 74 companies across 2,781 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cohen-Gadol's costs compare to other magnetic resonance imaging clinic/centers in Thousand Oaks?
Dr. Cohen-Gadol's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cohen-Gadol) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Magnetic Resonance Imaging Clinic/centers in Thousand Oaks
Browse magnetic resonance imaging clinic/centers in Thousand Oaks ranked by procedure volume and transparency data.
Highest volume
Top Magnetic Resonance Imaging Clinic/centers in CA
Magnetic resonance imaging clinic/centers ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Magnetic Resonance Imaging Clinic/centers in CA
Which CA magnetic resonance imaging clinic/centers receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Horizon Therapeutics plc Payments to Doctors
See all physicians who received payments from Horizon Therapeutics plc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology